Here we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases including acute kidney injury and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly we discuss the clinical management of COVID-19 patients with existing chronic renal disorders particularly those in dialysis and with kidney transplants. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.